Menu

Price Performance Heatmap

5Y Price (Market Cap Weighted)

All Stocks (15)

Company Market Cap Price
TSCO Tractor Supply Company
Pet care and veterinary services components of TSCO's ecosystem (Pet Rx, Allivet integration).
$28.69B
$54.10
-0.03%
CHWY Chewy, Inc.
Chewy Health and Vet Care clinics position Chewy in pet care and veterinary services.
$14.00B
$33.72
-2.18%
SJM The J. M. Smucker Company
Meow Mix, Milk-Bone, Pup-Peroni, and other pet foods place Smucker as a major pet care/animal nutrition producer.
$11.03B
$103.48
+1.11%
ELAN Elanco Animal Health Incorporated
Pet care & veterinary services channel through which the company distributes its animal health products.
$11.00B
$22.14
-1.91%
SPB Spectrum Brands Holdings, Inc.
Global Pet Care and pet-focused brands (Goodn'Fun, DreamBone, Nature's Miracle) place Spectrum Brands squarely in pet care products and services.
$1.35B
$53.88
-1.70%
WOOF Petco Health and Wellness Company, Inc.
Pet care and veterinary services (vet hospitals, grooming) are a key differentiator and revenue source.
$767.01M
$3.17
-6.76%
DOGZ Dogness (International) Corporation
Grooming-related products and grooming services position the company in Pet Care & Veterinary Services.
$161.04M
$11.97
+3.46%
BARK BARK, Inc.
Pet Care & Veterinary Services aligns with Bark's dog-centric pet care product focus.
$153.72M
$0.91
-2.62%
VNRX VolitionRx Limited
Nu.Q Vet is VolitionRx's animal-health diagnostic test line, placing the company in Pet Care & Veterinary Services.
$44.71M
$0.43
-1.68%
MDCX Medicus Pharma Ltd. Common Stock
D-MNA veterinary oncology program expands the platform into animal health.
$36.47M
$2.45
-0.81%
RDGL Vivos Inc.
IsoPet is marketed for veterinary oncology, placing the company in pet care/veterinary health.
$36.05M
$0.08
PETV PetVivo Holdings, Inc.
Company operates in the pet care and veterinary market, supplying veterinary devices and therapies.
$21.12M
$1.46
JCTC Jewett-Cameron Trading Company Ltd.
Lucky Dog pet products are part of the company's pet care product line.
$10.48M
$3.25
+3.83%
GELS Gelteq Limited Ordinary Shares
Pet care is a major vertical for Gelteq's gel-based delivery solutions, fitting the Pet Care & Veterinary Services category.
$9.58M
$1.17
YCBD cbdMD, Inc.
Pet CBD products (Paw CBD) indicate a pet care product line within the company’s portfolio.
$7.79M
$0.88
-0.01%

Loading company comparison...

# Executive Summary * The Pet Care & Veterinary Services industry is currently navigating significant macroeconomic headwinds, primarily persistent inflation and tariffs, which are increasing input costs and forcing consumers to trade down or delay purchases. * Technological innovation in AI, telehealth, and IoT devices is creating new growth avenues and separating tech-forward leaders from incumbents. * The long-term demand outlook remains robust, underpinned by the foundational trend of pet humanization, which supports premiumization and spending on health and wellness. * E-commerce continues to gain share, with subscription models providing resilient, recurring revenue streams, though these are being tested by consumer budget constraints. * The competitive landscape is diverging between technology-driven platforms, integrated omnichannel service providers, and large consumer packaged goods (CPG) brands navigating cost pressures. * We anticipate continued bifurcation in financial performance, with growth accruing to companies that leverage technology and serve non-discretionary health needs, while those exposed to tariffs and commoditized products will likely underperform. ## Key Trends & Outlook The Pet Care & Veterinary Services industry is currently grappling with significant macroeconomic headwinds, as persistent inflation and tariffs directly compress margins and alter consumer behavior. Overall pet prices have surged 29% since 2019, with veterinary fees alone rising 11% in 2025, forcing pet owners to seek cheaper alternatives and delay non-essential care. This financial strain directly impacts corporate profitability through both lower demand and higher input costs, a mechanism starkly illustrated by tariffs on imported goods. Diversified CPG players are particularly vulnerable; for example, The J. M. Smucker Company (SJM) reported an 87% decline in operating income in Q1 FY26, citing tariffs and high costs as primary drivers. This environment creates a clear divergence between companies that can manage costs and those exposed to volatile inputs, a trend we expect to continue for the next 12-18 months. In contrast to macroeconomic pressures, technological advancement is unlocking new growth frontiers. The rise of veterinary telehealth, projected to become a nearly $2 billion market by 2034, is making care more accessible. Simultaneously, the proliferation of IoT and smart devices is creating an entirely new product category focused on data-driven pet wellness. Companies that are leaders in these areas are capturing disproportionate growth. Dogness (International) Corporation (DOGZ) achieved 39.5% year-over-year revenue growth in FY2025, driven by a 43.7% increase in intelligent pet product sales. Chewy, Inc.'s (CHWY) investment in its Chewy Vet Care platform is a strategic move to capture the telehealth opportunity. The greatest opportunity lies in leveraging technology to meet the demands of "pet humanization," delivering personalized nutrition, remote health monitoring, and advanced veterinary care that commands premium pricing. The primary risk is continued cost inflation—from inputs, labor, and tariffs—eroding consumer purchasing power to a point where even non-discretionary spending on pet health is significantly curtailed, pressuring volumes and margins across the industry. ## Competitive Landscape The U.S. pet care market is a large and fragmented ~$140 billion industry. However, corporate consolidation is increasing in the veterinary services space, with corporations now operating 75% of specialty and emergency veterinary practices. This dynamic environment fosters several distinct competitive strategies. One dominant strategy involves building a massive e-commerce platform with a sticky subscription model for consumables, then layering on higher-margin services like telehealth and insurance. This approach benefits from highly predictable, recurring revenue from subscriptions and rich customer data for effective cross-selling. However, it faces high customer acquisition costs and intense competition on product pricing. Chewy, Inc. (CHWY) exemplifies this model, with its Autoship program accounting for a record 82.2% of net sales in Q1 FY2025, and the company is now expanding aggressively into services with Chewy Vet Care. In contrast, other players compete by integrating a physical retail footprint with high-touch services like veterinary care, grooming, and training as a key differentiator and traffic driver. This omnichannel approach creates a competitive moat that pure-play e-commerce cannot easily replicate, with physical locations serving as convenient hubs for both shopping and services. Petco Health and Wellness Company, Inc. (WOOF) operates over 1,500 pet care centers and views its owned vet hospitals and grooming services as its core competitive advantage, while undertaking a multi-phased transformation to restore profitability. This model, however, is exposed to high fixed costs of real estate and labor, as well as the veterinary labor shortage and wage inflation. Further differentiation is seen in niche lifestyle retailers and technology-driven product innovators. Tractor Supply Company (TSCO) dominates the rural lifestyle market, consistently gaining market share by catering specifically to the needs of farmers and ranchers, a strategy that insulates it from broader retail pressures. This model benefits from a resilient business and loyal customer base but has a limited total addressable market. Dogness (International) Corporation (DOGZ) represents the technology-driven product innovator, strategically transforming into a player focused on intelligent pet devices and an IoT platform, with its growth explicitly driven by its portfolio of proprietary technology in app-controlled feeders, smart wearables, and pet robots. This strategy offers high margins on proprietary technology but requires significant R&D investment and faces risks of rapid technological obsolescence. ## Financial Performance ### Revenue Revenue performance clearly separates the industry into two camps: technology-driven growers and macro-pressured laggards. Dogness (International) Corporation (DOGZ) exemplifies the technology tailwind, achieving 39.5% year-over-year total revenue growth in FY2025, primarily driven by a 43.7% increase in intelligent pet product sales. This demonstrates how innovation in new product categories can drive substantial top-line expansion. Conversely, companies heavily exposed to macroeconomic headwinds are experiencing significant pressure. The J. M. Smucker Company (SJM) reported a 1% year-over-year decline in net sales in Q1 FY26, reflecting the acute impact of inflation and shifting consumer spending patterns on its pet food and snacks segment. This bifurcation highlights the vulnerability of companies in more commoditized categories to rising costs and consumer trade-downs. {{chart_0}} ### Profitability The industry's primary challenge is defending margins against rising costs, leading to significant compression and divergence in profitability. The J. M. Smucker Company (SJM) is an essential example, with its operating income plummeting 87% in Q1 FY26, primarily due to high coffee costs and tariffs. This dramatic decline illustrates how rising input costs can severely decimate profitability for companies exposed to volatile commodities and tariffs. In contrast, Tractor Supply Company (TSCO) maintained a healthy gross margin of 36.9% in Q2 2025. This suggests that its niche positioning in the rural lifestyle market, coupled with a specialized product assortment, provides some insulation against broader inflationary pressures, allowing it to better preserve its profitability. {{chart_1}} ### Capital Allocation Capital allocation in the industry reflects a theme of prudence and strategic focus, with companies prioritizing balance sheet health and targeted investments. The J. M. Smucker Company (SJM) is prioritizing debt reduction following its Hostess acquisition, targeting approximately $500 million in annual paydowns over the next two years to achieve a leverage ratio below 3x net debt to adjusted EBITDA by the end of fiscal year 2027. This highlights a broader industry focus on deleveraging to build resilience. Concurrently, companies are making targeted bets on the future. Chewy, Inc. (CHWY) is financing its acquisition of SmartEquine, a leading U.S. provider of equine health products, through its existing balance sheet. This demonstrates a willingness to deploy capital for strategic assets that expand its ecosystem and capture new growth opportunities, even in a cautious environment. ### Balance Sheet The industry's overall balance sheet position is in a state of deliberate repair and strengthening. While specific cash and debt levels are not consistently provided across all companies, strategic actions indicate a clear focus on improving financial health. Elanco Animal Health Incorporated (ELAN) provides a representative proof point for this trend, having improved its year-end 2025 net leverage target to 3.9x to 4.3x through strategic monetization of Lotilaner U.S. royalties. This focus on deleveraging and ensuring ample liquidity is a priority for major players to navigate the current uncertain economic environment. {{chart_2}}
CHWY Chewy, Inc.

Chewy to Acquire SmartEquine in All‑Cash Deal to Expand Equine Health Portfolio

Oct 30, 2025
BARK BARK, Inc.

BARK Launches Subscriber Perks Program Offering Up to $1,500 in Annual Value

Oct 28, 2025
PETV PetVivo Holdings, Inc.

PetVivo Adds Josh Ruben, Managing Director of Life Sciences at Trinity Capital, to Board of Directors

Oct 28, 2025
RDGL Vivos Inc.

Vivos Inc. Appoints Top FDA Regulatory Expert to Advance RadioGel IDE Submission

Oct 27, 2025
TSCO Tractor Supply Company

Tractor Supply Reports Strong Q3 2025 Earnings, Narrows Fiscal 2025 Guidance

Oct 23, 2025
DOGZ Dogness (International) Corporation

Dogness (International) Reports Strong Fiscal 2025 Results, Net Loss Narrowed to $5.1 Million

Oct 17, 2025
VNRX VolitionRx Limited

VolitionRx Announces Proposed Public Offering of Common Stock and Warrants

Oct 10, 2025
RDGL Vivos Inc.

Vivos Inc. Board Authorizes Establishment of Corporate Entity in India

Sep 29, 2025
CHWY Chewy, Inc.

MoffettNathanson Upgrades Chewy to Buy, Citing Pet Household Recovery

Sep 25, 2025
CHWY Chewy, Inc.

Chewy Reports Strong Second Quarter Fiscal Year 2025 Results and Raises Full-Year Sales Outlook

Sep 10, 2025
RDGL Vivos Inc.

Vivos Inc. Demonstrates Exceptional Precision of Precision Radionuclide Therapy in Clinical Studies

Sep 08, 2025
RDGL Vivos Inc.

Vivos Inc. Files Provisional Patent for Hydrogel Electron Beam Sterilization Process

Sep 03, 2025
CHWY Chewy, Inc.

Roborock Launches Smart Cleaning Solutions for Pet Parents on Chewy

Aug 19, 2025
RDGL Vivos Inc.

FDA Declines Vivos Inc.'s RadioGel® IDE Application for Mayo Clinic Human Trials

Aug 14, 2025
RDGL Vivos Inc.

Vivos Inc. Submits Investigational Device Exemption (IDE) Application to FDA for RadioGel® Human Clinical Trials

Jul 14, 2025
CHWY Chewy, Inc.

Life is Good® Brand Launches Pet Products and Apparel on Chewy

Jul 09, 2025
CHWY Chewy, Inc.

Chewy Added to Multiple Russell Indexes

Jun 30, 2025
CHWY Chewy, Inc.

Chewy Announces Pricing of Upsized Stock Offering by Selling Stockholder and Increased Concurrent Repurchase

Jun 23, 2025
CHWY Chewy, Inc.

Chewy Reports Strong First Quarter Fiscal Year 2025 Results, Exceeding Sales Guidance

Jun 11, 2025
DOGZ Dogness (International) Corporation

Dogness Announces Strategic Investment in Petcare Internet of Things Platform, DITC

May 19, 2025
RDGL Vivos Inc.

Vivos Inc. Certifies University of Florida Veterinary Hospital for IsoPet® Therapy

May 15, 2025
CHWY Chewy, Inc.

Chewy CFO David Reeder to Depart, Company Reaffirms Q1 Guidance

May 12, 2025
DOGZ Dogness (International) Corporation

Dogness Secures US$6.0 Million Through Private Placement of Class A Common Shares

May 08, 2025
RDGL Vivos Inc.

Vivos Inc.'s IsoPet® Division Achieves Record-Breaking Q1 2025 Growth in Animal Cancer Treatments

Apr 23, 2025
RDGL Vivos Inc.

Vivos Inc. Details Continued Progress and Efficacy Signals in India RadioGel® Human Trial

Apr 15, 2025
CHWY Chewy, Inc.

eufy Launches Pet Monitoring and Smart Cleaning Solutions on Chewy

Apr 09, 2025
DOGZ Dogness (International) Corporation

Dogness Reports Robust Half-Year Financial Results with 81.1% Revenue Growth and Reduced Net Loss

Mar 31, 2025
CHWY Chewy, Inc.

Chewy Reports Strong Fourth Quarter and Full Year Fiscal Year 2024 Results, Returns to Active Customer Growth

Mar 26, 2025
CHWY Chewy, Inc.

Maev, a Leading Raw Dog Food Brand, Launches on Chewy

Feb 04, 2025
RDGL Vivos Inc.

Vivos Inc. Reports Positive Safety Data from Initial RadioGel® Human Clinical Trial Patients

Feb 04, 2025
CHWY Chewy, Inc.

Mizuho Securities Upgrades Chewy to Outperform with Strong 2025 Outlook

Jan 06, 2025
CHWY Chewy, Inc.

Wolfe Research Upgrades Chewy to Outperform, Citing Multiple Growth Drivers

Jan 03, 2025
RDGL Vivos Inc.

Vivos Inc.'s IsoPet® Division Reports Significant Growth and Strategic Milestones in 2024

Dec 26, 2024
RDGL Vivos Inc.

Vivos Inc. Initiates First Human Clinical Trial for RadioGel® in India

Dec 23, 2024
CHWY Chewy, Inc.

Chewy's Largest Shareholder Commences Public Offering with Concurrent Company Repurchase

Dec 11, 2024
CHWY Chewy, Inc.

Chewy Reports Third Quarter Fiscal Year 2024 Financial Results

Dec 04, 2024
CHWY Chewy, Inc.

Chewy Set to Join S&P MidCap 400 Index

Nov 01, 2024
CHWY Chewy, Inc.

Influential Trader 'Roaring Kitty' Dumps Entire Stake in Chewy

Oct 30, 2024
RDGL Vivos Inc.

Vivos Inc. Expands IsoPet® Network with NorthStar Vets Certification

Oct 18, 2024
DOGZ Dogness (International) Corporation

Dogness Reports Fiscal Year 2024 Financial Results: Revenue Declines Amid Intelligent Pet Product Sales Drop

Oct 16, 2024

The most compelling investment themes are the ones nobody is talking about yet.

Every Monday, get three under-the-radar themes with catalysts, data, and stocks poised to benefit.

Sign up now to receive them!

Also explore our analysis on 5,000+ stocks